nRichDX Launches New CTC Enrichment Kit
/PRNewswire/ -- nRichDX® has launched its new RUO-labeled CTC enrichment kit that uniquely isolates Circulating Tumor Cells (CTCs) from up to 40mL of whole...
Stay updated with breaking news from Accessed August. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- nRichDX® has launched its new RUO-labeled CTC enrichment kit that uniquely isolates Circulating Tumor Cells (CTCs) from up to 40mL of whole...
TOFIDENCE becomes the first tocilizumab biosimilar to gain FDA approval in the United StatesFDA approval is based on a robust analytical, non-clinical and clinical data package comparing TOFIDENCE to...
The Janssen Pharmaceutical Companies of Johnson & Johnson, in collaboration with the Advanced Practitioner Society for Hematology and Oncology (APSHO), today announced the launch of Make It HAPPen™, a multi-year effort designed to recognize and support Advanced Practice Providers (APPs) in the life-changing care ...
CSL Seqirus secures multi-year pandemic preparedness agreement as part of its continued partnership with the UK government CSL Seqirus...
UCB announces approval of RYSTIGGO® (rozanolixizumab) and ZILBRYSQ® (zilucoplan) for the treatment of adult patients with generalized myasthenia gravis in JapanJapanese Ministry of Health, Labour and Welfare (MHLW) approves two UCB treatments, RYSTIGGO® (rozanolixizumab) and ZILBRYSQ® (zilucoplan), f...